What causes nt in pregnancy

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 4, 2026

Quick Answer: NT stands for Nuchal Translucency, and an increased NT measurement in pregnancy is not a cause of anything, but rather an indicator. It refers to the amount of fluid accumulated behind the baby's neck during the first trimester. An increased measurement can suggest a higher risk of certain chromosomal abnormalities or congenital conditions.

Key Facts

Increased NT is not a diagnosis, but a risk indicator.
It measures fluid behind the baby's neck between 11 and 14 weeks of gestation.
A measurement above 3.5 mm is generally considered increased.
It is often part of the first-trimester screening test.
Further diagnostic tests like amniocentesis or CVS may be recommended if NT is increased.

What is Nuchal Translucency (NT) in Pregnancy?

The Nuchal Translucency (NT) scan is a routine part of prenatal screening offered to pregnant individuals, typically between 11 and 14 weeks of gestation. It is an ultrasound measurement of the fluid-filled space at the back of a baby's neck. All fetuses have a small amount of fluid in this area, but an increased amount of fluid can be associated with a higher risk of certain chromosomal abnormalities, such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13), as well as other genetic syndromes and certain congenital heart defects.

Understanding the NT Scan

The NT scan is performed by a trained sonographer who measures the thickness of the nuchal translucency. The measurement is taken from the skin to the inner lining of the nuchal skin. A measurement of 3.5 millimeters (mm) or greater is generally considered increased, though this threshold can vary slightly depending on the gestational age and the specific guidelines followed by the healthcare provider.

It is crucial to understand that an increased NT measurement does not definitively diagnose a condition. Instead, it serves as a screening tool, indicating an elevated risk. The NT measurement is often combined with other factors, such as the pregnant person's age and levels of specific hormones measured in the blood (part of the first-trimester combined screening), to calculate a more precise risk assessment for chromosomal abnormalities.

Why Does Increased NT Occur?

The exact reasons why some fetuses develop an increased NT are not fully understood. However, several theories exist:

Chromosomal Abnormalities: In fetuses with chromosomal conditions like Down syndrome, there can be impaired development of the lymphatic system, leading to fluid accumulation in the nuchal space. This impaired lymphatic drainage is thought to be a significant factor.
Congenital Heart Defects: There is a known association between an increased NT and congenital heart defects. The fluid accumulation might be a sign of underlying cardiac issues that affect fluid circulation and drainage.
Genetic Syndromes: Other rare genetic syndromes can also be associated with an increased NT measurement.
Other Factors: While less common, factors such as maternal health conditions, certain infections, or even variations in fetal anatomy can sometimes contribute to a slightly increased NT measurement. However, the primary concern with a significantly elevated NT remains chromosomal and structural abnormalities.

What Happens if the NT Measurement is Increased?

If the NT measurement is found to be increased, the healthcare provider will discuss the implications with the pregnant person. This typically involves:

Counseling: A genetic counselor or maternal-fetal medicine specialist will explain the increased risk and the implications of the findings.
Further Screening: The combined screening results (NT and blood tests) will provide a risk percentage.
Diagnostic Testing: To obtain a definitive diagnosis, diagnostic tests are usually recommended. These include:
- Chorionic Villus Sampling (CVS): This test involves taking a small sample of placental tissue, typically performed between 10 and 13 weeks of gestation.
- Amniocentesis: This test involves taking a small sample of amniotic fluid, usually performed after 15 weeks of gestation.
Both CVS and amniocentesis can analyze the baby's chromosomes and provide a definitive diagnosis for chromosomal abnormalities.
Detailed Anatomy Scan: A more detailed ultrasound examination, often performed later in the pregnancy, may be recommended to look for specific structural abnormalities, especially heart defects.

Limitations and Considerations

It is important to remember that the NT scan is a screening test, not a diagnostic test. A normal NT measurement does not guarantee that the baby is free from chromosomal abnormalities or other conditions, and an increased NT measurement does not mean the baby will definitely have a problem. The accuracy of the NT scan depends on several factors, including the skill of the sonographer, the quality of the ultrasound equipment, and the gestational age at which the scan is performed. Early or late scans can lead to less accurate measurements.

The decision to undergo NT screening and any subsequent diagnostic testing is a personal one. It is essential to have open discussions with your healthcare provider to understand the benefits, risks, and limitations of each test to make informed choices throughout your pregnancy.